Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial

Kanna Health announces FDA and MHRA approvals to begin its Phase 1 clinical trial for the development of KH-001 as first FDA-approved treatment for premature ejaculation

Kanna Health announces patent application publication for KH-001 as premature ejaculation treatment

Kanna Health announces patent application publication for KH-001 as premature ejaculation treatment